Topic
diabetic macular edema
News
19 Feb 2026
Zydus launches biosimilar Aflibercept 2 mg ANYRA™ for advancing ophthalmic care
Zydus Lifesciences Ltd, today announced the launch of Anyra™, India's first indigenously developed biosimilar of Aflibercept 2 mg. Zydus has…
Global News
3 May 2021
Novartis Phase III BEOVU data show potential in more diabetic macular edema patients
The Phase III KESTREL and KITE studies enrolled a total of 926 patients in 36 countries Novartis announced positive one-year…